Stanford University
Showing 3,801-3,810 of 7,809 Results
-
Joshua Landy
Andrew B. Hammond Professor of French Language, Literature and Civilization, and Professor of Comparative Literature and, by courtesy, of English and of Philosophy
BioJoshua Landy is the Andrew B. Hammond Professor of French, Professor of Comparative Literature, and co-director of the Literature and Philosophy Initiative at Stanford, home to a PhD minor and undergraduate major tracks in Philosophy and Literature.
Professor Landy is the author of Philosophy as Fiction: Self, Deception, and Knowledge in Proust (Oxford, 2004), How To Do Things with Fictions (Oxford, 2012), and The World According to Proust (Oxford, 2023). He is also the co-editor of two volumes, Thematics: New Approaches (SUNY, 1995, with Claude Bremond and Thomas Pavel) and The Re-Enchantment of the World: Secular Magic in a Rational Age (Stanford, 2009, with Michael Saler). Philosophy as Fiction deals with issues of self-knowledge, self-deception, and self-fashioning in Proust's "A la recherche du temps perdu," while raising the question of what literary form contributes to an engagement with such questions. How to Do Things with Fictions explores a series of texts (by Plato, Beckett, Mallarmé, and Mark) that function as training-grounds for the mental capacities. The World According to Proust (now in paperback as Marcel Proust: A Very Short Introduction) is a reader's guide to "In Search of Lost Time."
Professor Landy has published essays in Critical Inquiry, New Literary History, Poetics Today, Narrative, SubStance, Arion, The Los Angeles Review of Books, the Wall Street Journal, and other venues, as well as chapters in The Oxford Handbook of Cognitive Approaches to Literature, The Blackwell Companion to the Philosophy of Literature, and The Cambridge Companion to Proust.
Since 2017, Professor Landy has co-hosted the nationally syndicated public radio show "Philosophy Talk." He has also appeared on the NPR shows "Forum" and "To the Best of our Knowledge."
Professor Landy has received the Walter J. Gores Award for Teaching Excellence (1999) and the Dean's Award for Distinguished Teaching (2001). As of Fall 2024, he is the Eleanor Loring Ritch University Fellow in Undergraduate Education. -
Alfred Lane
Professor of Dermatology and of Pediatrics at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsDeveloping gene therapy for genetic skin diseases is my major focus. Prior to that, we are developing methods to give effective and efficient care to infants with rare and disabling genetic skin diseases including epidermolysis bullosa and ichthyosis as well as infants and children with unusual and difficult to manage vascular malformations. I am also interested in clinical studies within the NICU protecting premature infants skin and clinical studies in children with common skin diseases.
-
Barton Lane
Professor of Radiology (Diagnostic Radiology) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsAs a professor in the Medical Center Line, my primary investigative interest has been in clinical neuroradiology. This encompasses spinal cord and spine disease, degenerative and demyelinating diseases of the central nervous system, strokes and infarction, and chronic epilepsy syndromes. Facial and head and neck vascular malformations and hemangiomas have been a focus of interest for many years, with collaborative projects involving dermatology and functional restoration services.
-
Curtis Langlotz
Senior Associate Vice Provost for Research, Professor of Radiology (Integrative Biomedical Imaging Informatics), of Medicine (BMIR), of Biomedical Data Science and Senior Fellow at the Stanford Institute for Human-Centered AI
Current Research and Scholarly InterestsMy laboratory develops machine learning methods to help physicians detect disease and eliminate diagnostic errors. My laboratory is developing neural network systems that detect and classify disease on medical images. We also develop natural language processing methods that use the narrative radiology report for contrastive learning and other multi-modal methods that improve the accuracy and capability of machine learning systems.
-
Marvin Langston
Assistant Professor of Epidemiology and Population Health and, by courtesy, of Urology
BioDr. Marvin Langston is an Assistant Professor of Epidemiology and Population Health. He is a member of the Stanford Cancer Institute and Urologic Cancer Epidemiology Lab. He is an epidemiologist by training who focuses on the fields of benign prostate and pelvic conditions and urological cancers including prostate and kidney cancers.
Prior to Stanford, he served as a Research Scientist in the Division of Research at Kaiser Permanente Northern California. Dr. Langston received his PhD in Epidemiology from the University of Arizona’s College of Public Health followed by postdoctoral training in Cancer Prevention and Control at Washington University in Saint Louis School of Medicine.
His program of research intends to characterize and measure infectious agents, environmental toxicants, and lifestyle factors; to evaluate the role of these factors in urological cancer etiology and outcomes; and to identify populations at high risk of exposure to these factors. So far he has focused this research to address the following questions: 1) What role do sexually transmitted infections and other systemic infections have in prostate damage and ensuing prostate cancer risk? 2) How can we appropriately model and define early life risk factors for urological cancers? 3) Can we harmonize molecular and clinical aspects of urological condition diagnoses to produce well characterized outcomes for biomarker discovery and etiological investigation? He has primarily addressed these questions using a variety of molecular and clinical epidemiology approaches while developing expertise in the cross-cutting theme of cancer health disparities with particular interests in the cancer care experiences of sexual and gender minorities and racial/ethnic minorities.
Dr. Langston has been studying the impact of exogenous factors on prostate specific antigen (PSA) concentration in young men as a marker of prostate damage and inflammation for over a decade. As early life PSA has been found predictive of future prostate cancer mortality, he has now setout to optimize risk-stratified screening for prostate cancer. This promising approach uses men’s baseline PSA values to inform their risk of future aggressive and/or fatal prostate cancer and determine their frequency of further screening. Under this approach, men with high baseline age-specific total PSA levels receive more frequent screening and men with lower levels receive less frequent screening. Dr. Langston was awarded an R01 from NCI to evaluate this approach using historically collected biospecimen. His funded research trajectory to this point also includes four training awards (2-NCI and 2-NIDDK) and several internal grants. Dr. Langston was selected in the inaugural class of the White House Cancer Moonshot Scholars for his work. -
Benjamin Laniakea
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Benji Laniakea serves as the chief of the Stanford LGBTQ+ Adult Clinical Program, which offers comprehensive and tailored healthcare for the LGBTQ+ patient population for patients of all ages, sexualities, and gender identities. They also serve as the theme lead for the Sex, Gender, Sexuality, and Sexual Function curriculum at the Stanford School of Medicine for which they received the Arthur L. Bloomfield Award.
-
Maarten Lansberg, MD, PhD
Professor of Neurology and Neurological Sciences (Adult Neurology) and, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsMy research involves the design and conduct of clinical trials to discover new treatments for patients who have suffered a stroke. These trials span treatment of acute stroke, stroke recovery, and stroke prevention. My research in acute stroke is primarily focused on the use of advanced neuroimaging methods (CT and MRI) to select patients who are most likely to benefit from therapies aimed at restoring blood flow to the brain in patients who have suffered a stroke.
-
Patrick Lanter
Clinical Assistant Professor, Emergency Medicine
BioPATRICK LANTER, MD, MPH FACEP is an assistant professor in the Department of Emergency Medicine at Stanford University. Dr. Lanter previously completed a 2-year ultrasound fellowship and 2-year global emergency medicine at Stanford and has completed his master's in public health at the University of California Berkeley. He completed his emergency medicine residency at Washington University in St. Louis where he served as Chief Resident. He completed his medical school training at the University of Illinois, Chicago and was a member of the Global Medicine Program during his time there. His work has focused on the development of a sustainable ultrasound training program at the University Teaching Hospital of Kigali in Rwanda. Additionally, he has served as a course instructor for 2 Stanford courses (Medical Student Introduction of POCUS and Point of Care Ultrasound Clerkship), and the Emergency Medicine Clerkship at the University of Global Health Equity in Butaro, Rwanda.
